312 related articles for article (PubMed ID: 25714016)
1. Circulation long non-coding RNAs act as biomarkers for predicting tumorigenesis and metastasis in hepatocellular carcinoma.
Tang J; Jiang R; Deng L; Zhang X; Wang K; Sun B
Oncotarget; 2015 Feb; 6(6):4505-15. PubMed ID: 25714016
[TBL] [Abstract][Full Text] [Related]
2. Circulating LncRNAs Serve as Diagnostic Markers for Hepatocellular Carcinoma.
Yuan W; Sun Y; Liu L; Zhou B; Wang S; Gu D
Cell Physiol Biochem; 2017; 44(1):125-132. PubMed ID: 29130980
[TBL] [Abstract][Full Text] [Related]
3. Circulating exosome-derived bona fide long non-coding RNAs predicting the occurrence and metastasis of hepatocellular carcinoma.
Lu Y; Duan Y; Xu Q; Zhang L; Chen W; Qu Z; Wu B; Liu W; Shi L; Wu D; Yang Y; Sun D; Chen X
J Cell Mol Med; 2020 Jan; 24(2):1311-1318. PubMed ID: 31811749
[TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNA PANDAR correlates with poor prognosis and promotes tumorigenesis in hepatocellular carcinoma.
Peng W; Fan H
Biomed Pharmacother; 2015 May; 72():113-8. PubMed ID: 26054684
[TBL] [Abstract][Full Text] [Related]
5. Four Circulating Long Non-Coding RNAs Act as Biomarkers for Predicting Cervical Cancer.
Sun W; Wang L; Zhao D; Wang P; Li Y; Wang S
Gynecol Obstet Invest; 2018; 83(6):533-539. PubMed ID: 30134241
[TBL] [Abstract][Full Text] [Related]
6. lncRNA-D16366 Is a Potential Biomarker for Diagnosis and Prognosis of Hepatocellular Carcinoma.
Chao Y; Zhou D
Med Sci Monit; 2019 Sep; 25():6581-6586. PubMed ID: 31475695
[TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNA XLOC_010235 correlates with poor prognosis and promotes tumorigenesis of hepatocellular carcinoma.
Yang F; Jiang Y; Lv LZ
Eur Rev Med Pharmacol Sci; 2017 Nov; 21(21):4867-4874. PubMed ID: 29164575
[TBL] [Abstract][Full Text] [Related]
8. Investigation of serum lncRNA-uc003wbd and lncRNA-AF085935 expression profile in patients with hepatocellular carcinoma and HBV.
Lu J; Xie F; Geng L; Shen W; Sui C; Yang J
Tumour Biol; 2015 May; 36(5):3231-6. PubMed ID: 25501706
[TBL] [Abstract][Full Text] [Related]
9. HULC and Linc00152 Act as Novel Biomarkers in Predicting Diagnosis of Hepatocellular Carcinoma.
Li J; Wang X; Tang J; Jiang R; Zhang W; Ji J; Sun B
Cell Physiol Biochem; 2015; 37(2):687-96. PubMed ID: 26356260
[TBL] [Abstract][Full Text] [Related]
10. Association of long noncoding RNA and c-JUN expression in hepatocellular carcinoma.
El-Tawdi AH; Matboli M; El-Nakeep S; Azazy AE; Abdel-Rahman O
Expert Rev Gastroenterol Hepatol; 2016 Jul; 10(7):869-77. PubMed ID: 27215316
[TBL] [Abstract][Full Text] [Related]
11. Up-regulation of long non-coding RNA Sox2ot promotes hepatocellular carcinoma cell metastasis and correlates with poor prognosis.
Shi XM; Teng F
Int J Clin Exp Pathol; 2015; 8(4):4008-14. PubMed ID: 26097588
[TBL] [Abstract][Full Text] [Related]
12. Three circulating long non-coding RNAs act as biomarkers for predicting NSCLC.
Tang Q; Ni Z; Cheng Z; Xu J; Yu H; Yin P
Cell Physiol Biochem; 2015; 37(3):1002-9. PubMed ID: 26393913
[TBL] [Abstract][Full Text] [Related]
13. Identification of long non-coding RNA
Luo P; Liang C; Zhang X; Liu X; Wang Y; Wu M; Feng X; Tu J
Biosci Rep; 2018 Aug; 38(4):. PubMed ID: 29559565
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA301 is a potential diagnostic biomarker for hepatocellular cancer.
He K; Hu Z; Ruan J; Ma Q; Zhong F; Cheng X; Sun S; Zhou J
Int J Clin Exp Pathol; 2015; 8(5):5603-8. PubMed ID: 26191271
[TBL] [Abstract][Full Text] [Related]
15. Hepatic miR-126 is a potential plasma biomarker for detection of hepatitis B virus infected hepatocellular carcinoma.
Ghosh A; Ghosh A; Datta S; Dasgupta D; Das S; Ray S; Gupta S; Datta S; Chowdhury A; Chatterjee R; Mohapatra SK; Banerjee S
Int J Cancer; 2016 Jun; 138(11):2732-44. PubMed ID: 26756996
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic utility of plasma lncRNA small nucleolar RNA host gene 1 in patients with hepatocellular carcinoma.
Gao S; Xu X; Wang Y; Zhang W; Wang X
Mol Med Rep; 2018 Sep; 18(3):3305-3313. PubMed ID: 30066898
[TBL] [Abstract][Full Text] [Related]
17. Latent transforming growth factor-beta binding protein-1 in circulating plasma as a novel biomarker for early detection of hepatocellular carcinoma.
Cao B; Yang L; Rong W; Feng L; Han N; Zhang K; Cheng S; Wu J; Xiao T; Gao Y
Int J Clin Exp Pathol; 2015; 8(12):16046-54. PubMed ID: 26884881
[TBL] [Abstract][Full Text] [Related]
18. The long noncoding RNAs PVT1 and uc002mbe.2 in sera provide a new supplementary method for hepatocellular carcinoma diagnosis.
Yu J; Han J; Zhang J; Li G; Liu H; Cui X; Xu Y; Li T; Liu J; Wang C
Medicine (Baltimore); 2016 Aug; 95(31):e4436. PubMed ID: 27495068
[TBL] [Abstract][Full Text] [Related]
19. Lnc-PCDH9-13:1 Is a Hypersensitive and Specific Biomarker for Early Hepatocellular Carcinoma.
Xie Z; Zhou F; Yang Y; Li L; Lei Y; Lin X; Li H; Pan X; Chen J; Wang G; Liu H; Jiang J; Wu B
EBioMedicine; 2018 Jul; 33():57-67. PubMed ID: 30045829
[TBL] [Abstract][Full Text] [Related]
20. Using circular RNA SMARCA5 as a potential novel biomarker for hepatocellular carcinoma.
Li Z; Zhou Y; Yang G; He S; Qiu X; Zhang L; Deng Q; Zheng F
Clin Chim Acta; 2019 May; 492():37-44. PubMed ID: 30716279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
